Literature DB >> 27459311

Family history and the risk of colorectal cancer: The importance of patients' history of colonoscopy.

Korbinian Weigl1, Lina Jansen1, Jenny Chang-Claude2,3, Phillip Knebel4, Michael Hoffmeister1, Hermann Brenner5,6,7.   

Abstract

Registry-based studies on the risk of colorectal cancer (CRC) for persons with a family history (FH) typically did not control for important covariates, such as history of colonoscopy. We aimed to quantify the association between FH and CRC risk, carefully accounting for potential confounders. We conducted a population-based case-control study in Germany. A total of 4,313 patients with a first diagnosis of CRC (cases) and 3,153 controls recruited from 2003 to 2014 were included. We used multiple logistic regression analyses to assess the association between FH and risk of CRC with odds ratios (OR) and the resulting 95% confidence intervals (95% CI). A total of 582 cases (13.5%) and 321 (10.2%) controls reported a history of CRC in a first-degree relative, which was associated with a 41% increase in risk of CRC (OR: 1.41, 95% CI 1.22-1.63) after adjustment for sex and age. The OR substantially increased to 1.73 (95% CI, 1.48-2.03) after comprehensive adjustment including previous colonoscopies. Irrespective of their FH status, persons with history of colonoscopies had a lower CRC risk compared with persons without previous colonoscopies and without family history (OR: 0.25, 95% CI, 0.22-0.28 for persons without FH and OR 0.45, 95% CI, 0.36-0.56 for persons with FH). In an era of widespread use of colonoscopy, adjusting for previous colonoscopy is therefore crucial for deriving valid estimates of FH-related CRC risk. Colonoscopy reduces the risk of CRC among those with FH far below levels of people with no FH and no colonoscopy.
© 2016 UICC.

Entities:  

Keywords:  case-control study; colonoscopy; colorectal cancer; family history

Mesh:

Year:  2016        PMID: 27459311     DOI: 10.1002/ijc.30284

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

1.  Strongly enhanced colorectal cancer risk stratification by combining family history and genetic risk score.

Authors:  Korbinian Weigl; Jenny Chang-Claude; Phillip Knebel; Li Hsu; Michael Hoffmeister; Hermann Brenner
Journal:  Clin Epidemiol       Date:  2018-01-19       Impact factor: 4.790

2.  Quantitative risk of positive family history in developing colorectal cancer: A meta-analysis.

Authors:  Parsa Mehraban Far; Abdulaziz Alshahrani; Mohammad Yaghoobi
Journal:  World J Gastroenterol       Date:  2019-08-14       Impact factor: 5.742

3.  Lower Relative Contribution of Positive Family History to Colorectal Cancer Risk with Increasing Age: A Systematic Review and Meta-Analysis of 9.28 Million Individuals.

Authors:  Martin C S Wong; C H Chan; Jiayan Lin; Jason L W Huang; Junjie Huang; Yuan Fang; Wilson W L Cheung; C P Yu; John C T Wong; Gary Tse; Justin C Y Wu; Francis K L Chan
Journal:  Am J Gastroenterol       Date:  2018-06-05       Impact factor: 10.864

4.  Determining Risk of Colorectal Cancer and Starting Age of Screening Based on Lifestyle, Environmental, and Genetic Factors.

Authors:  Jihyoun Jeon; Mengmeng Du; Robert E Schoen; Michael Hoffmeister; Polly A Newcomb; Sonja I Berndt; Bette Caan; Peter T Campbell; Andrew T Chan; Jenny Chang-Claude; Graham G Giles; Jian Gong; Tabitha A Harrison; Jeroen R Huyghe; Eric J Jacobs; Li Li; Yi Lin; Loïc Le Marchand; John D Potter; Conghui Qu; Stephanie A Bien; Niha Zubair; Robert J Macinnis; Daniel D Buchanan; John L Hopper; Yin Cao; Reiko Nishihara; Gad Rennert; Martha L Slattery; Duncan C Thomas; Michael O Woods; Ross L Prentice; Stephen B Gruber; Yingye Zheng; Hermann Brenner; Richard B Hayes; Emily White; Ulrike Peters; Li Hsu
Journal:  Gastroenterology       Date:  2018-02-17       Impact factor: 33.883

5.  Investigation of methylenetetrahydrofolate reductase tagging polymorphisms with colorectal cancer in Chinese Han population.

Authors:  Sheng Zhang; Shuchen Chen; Yu Chen; Mingqiang Kang; Chao Liu; Hao Qiu; Yafeng Wang; Weifeng Tang
Journal:  Oncotarget       Date:  2017-06-29

6.  Association of PPARG rs 1801282 C>G polymorphism with risk of colorectal cancer: from a case-control study to a meta-analysis.

Authors:  Jiakai Jiang; Zhiqiang Xie; JunYing Guo; Yafeng Wang; Chao Liu; Sheng Zhang; Weifeng Tang; Yu Chen
Journal:  Oncotarget       Date:  2017-08-10

7.  Lack of association between screening interval and cancer stage in Lynch syndrome may be accounted for by over-diagnosis; a prospective Lynch syndrome database report.

Authors:  Toni T Seppälä; Aysel Ahadova; Mev Dominguez-Valentin; Finlay Macrae; D Gareth Evans; Christina Therkildsen; Julian Sampson; Rodney Scott; John Burn; Gabriela Möslein; Inge Bernstein; Elke Holinski-Feder; Kirsi Pylvänäinen; Laura Renkonen-Sinisalo; Anna Lepistö; Charlotte Kvist Lautrup; Annika Lindblom; John-Paul Plazzer; Ingrid Winship; Douglas Tjandra; Lior H Katz; Stefan Aretz; Robert Hüneburg; Stefanie Holzapfel; Karl Heinimann; Adriana Della Valle; Florencia Neffa; Nathan Gluck; Wouter H de Vos Tot Nederveen Cappel; Hans Vasen; Monika Morak; Verena Steinke-Lange; Christoph Engel; Nils Rahner; Wolff Schmiegel; Deepak Vangala; Huw Thomas; Kate Green; Fiona Lalloo; Emma J Crosbie; James Hill; Gabriel Capella; Marta Pineda; Matilde Navarro; Ignacio Blanco; Sanne Ten Broeke; Maartje Nielsen; Ken Ljungmann; Sigve Nakken; Noralane Lindor; Ian Frayling; Eivind Hovig; Lone Sunde; Matthias Kloor; Jukka-Pekka Mecklin; Mette Kalager; Pål Møller
Journal:  Hered Cancer Clin Pract       Date:  2019-02-28       Impact factor: 2.857

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.